Fever is a common clinical manifestation that has puzzled physicians for centuries. It is a symptom of an underlying condition, often an infection, and is a complex physiological response to disease. Understanding and managing fever appropriately is vital in clinical practice.
Fever is the body's natural response to a variety of conditions, most commonly infection. Pyrogens, substances that can cause fever, are released by the immune system in response to an insult. These pyrogens act on the hypothalamus, the body's thermostat, to increase the set point of body temperature, leading to fever.
Thorough history taking and physical examination are crucial in the evaluation of a febrile patient. The history should include recent travel, exposure to infectious diseases, and any underlying health conditions. Physical examination may reveal signs of infection or inflammation. Laboratory studies, including complete blood count, blood cultures, and inflammatory markers, can aid in identifying the cause of the fever.
Management of fever involves treating the underlying cause and managing the symptoms. Antipyretics, such as acetaminophen and ibuprofen, are commonly used to alleviate the discomfort associated with fever. However, it is crucial to remember that fever is a symptom and not a disease in itself. Therefore, the focus should be on identifying and treating the underlying cause.
Special considerations are necessary when managing fever in certain populations, such as infants, the elderly, and immunocompromised individuals. These patients may not exhibit the typical signs and symptoms of fever, making diagnosis and management more challenging.
Proper understanding of the physiology, assessment, and management of fever is essential for effective clinical practice. While fever is a common symptom, it often indicates an underlying condition that requires attention. Therefore, a comprehensive approach to managing fever is necessary to ensure optimal patient outcomes.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation